Rheumatoid arthritis (RA) is a chronic autoimmune disorder in which inflammation occurs in the synovial joint and synovial membrane, and in severe condition, it leads to erosion of cartilage and bone. The etiology of RA is still indescribable; generally, RA is a multifactorial disease, wherein complex interactions between patients and different factors such as environmental, genetic, and epigenetic factors determine the overall risk of disease. RA is classified based on the stage of disease. Treatment for RA is still a challenge for doctors and researchers. Effective treatment for RA can be achieved by decreasing disease activity or reduction of RA to other patients using currently available treatment options. This article gives a comprehensive perspective of data regarding different signaling pathways involved in RA development, factors affecting RA, stages of RA, and other treatments of RA. This article also suggests future research perspectives that would be helpful for the development of RA treatment (medicine) with more efficacy, safety profiles, and lower financial costs.